Interestingly, clusterin has also been shown to prevent LDL oxidation by arterial wall cells [14], suggesting that clusterin may play anti-atherogenic as well as anti-amyloidogenic roles [9], creating the rationale for investigating both atherosclerosis-related diseases and Alzheimer’s disease. This evidence concerns the gene CLU and Alzheimer disease.